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In parallel with the development of modern health systems and the growth of the welfare state, 
diseases have shifted towards chronic diseases. Today, instead of rapid-onset infections, most 
resources are focused on the long-term treatment of mostly lifelong chronic conditions. The 
condition for the effective use of therapies is to take the specified dose with the prescribed 
frequency and for the required period of time. If these parameters are met, we can talk about 
patient collaboration or adherence. For certain diseases and treatments, adherence is critically 
low. In the case of complex preparations to be taken several times a day, or diseases that do not 
cause serious, noticeable complaints, the initial number of patients treated is reduced to a fraction 
within a short time. As a result, economic harm is perceived not only by the patient but also by 
all those involved in the health care system, including pharmaceutical companies. However, the 
factors influencing patient collaboration vary widely. In order to achieve high adherence, the goal 
is to develop health services that coordinate the actors involved, the infrastructure, the 
communication, the material components to improve the user experience. As a user-centered 
methodology, service design can play a prominent role in the design of therapeutic services, 
contributing to the reduction of uncertainties in innovation processes. In my study, I assess the 
digital toolkit of patient education in Hungarian society. The aim is to explore digital tools and 
technologies that can contribute to the development of health awareness and education so that 
both science and the pharmaceutical and technology companies that exploit it can apply the 
results of research.  
Keywords: digitalization, digital transformation, adherence 






Knowledge of the concept of adherence is not new, but there have been few studies on the 
effectiveness, applicability, and success of therapeutic methods, especially in Hungary, so 
not only can research fill a gap, but it also provides innovative value to pharmaceutical 
companies and provides guidance to patients’ needs in a broader understanding. However, 
the factors influencing patient collaboration vary widely. In addition to patient-dependent 
health status, factors dependent on therapy, socioeconomic, health, and care staff also 
affect the success of adherence (World Health Organization, 2003).  
According to international data, about half of the patients remain on the prescribed 
therapy (World Health Organization, 2003), the data in Hungary are worse (Molnár, 
2011). We would like to examine what kind of digital device and technology could help 
to increase patient adherence among the Hungarian population in different age groups 
and different disease groups. The re-exacerbation of the disease, resulting from the 
discontinuation of therapy after the asymptomatic period (exacerbation), has a significant 
financial impact: the treatment of outpatient exacerbations is two to three times the cost 
of proper maintenance therapy. Poor adherence may result in unjustified drug changes, 
adjunctive therapies, or dose escalation (Berzai, 2017; Molnár & Dankó, 2010). In addition 
to the patient, the economic damage is felt by all those involved in the healthcare system, 
including pharmaceutical companies. Economic burdens attributable to quantified non-
adherence result in $ 100 billion in annual spending in the United States (Vermeire et al., 
2001), but an estimate from 2011 puts the economic damage caused by a lack of patient 
cooperation at $ 310 billion (Capgemini Consulting, 2011). 
The aim of the research is to explore the possibilities of applying the service design 
methodology in the design and implementation of user-friendly and experience-based 
health services. The research provides an opportunity to evaluate the digital educational 
effectiveness aspect of patients. The significance of the problem is shown by the fact that 
only 20-50 percent of patients consider cooperation to be appropriate (Molnár, 2011), 
thus, the social value of the research is enhanced by the fact that the exploration of 
Hungarian adherence relations on the basis of data affecting a wide population, in as many 
therapeutic areas as possible, can greatly help the development and successful application 




2. Theoretical background 
Thanks to the growing prevalence of digitalization in healthcare as well, the latest 
technologies are no longer available not only in healthcare institutions but also in our 
daily lives. The Covid epidemic has brought up to 5-8 years of progress in the digitalization 
of telemedicine and healthcare. These innovative solutions were already available on the 
market, but the pandemic has now forced their use (László, 2020). “Pharma digitalization 
facilitates the healthcare transformation. Pharma digitalization will help the pharma 
business become more patient-centric. Patients will gain more possibilities for better and 
cost-effective care outcomes.” (Kemppainen & Liikkanen, 2017). 
You can choose from a wide range of different mobile device applications and devices 
equipped with sensors to measure and record your health data, whether it is related to 
blood sugar levels or ovulation forecast. What we measured by at-home self-monitoring 
programs, can be shared immediately with our health care professional, who can remotely 
monitor and intervene in the therapy in a much more convenient and cost-effective way 
for both parties. In addition, the existing medical device products can be improved with 
sensor and connectivity technologies to collect data for further care analytics and 
personalized therapy (Kemppainen & Liikkanen, 2017). Moreover, it is now possible to 
find out about a health issue with the help of a specialist if required. By using the 
telemedicine service, the number of visits to the doctor can be reduced, waiting times can 
be avoided and the patient can get answers to his questions in a short time. It is also 
possible to detect digital biomarkers with high frequency, increasing the importance of 
health data reliability and digital diagnostics. Such tools may include but are not limited 
to, so-called wearables as smartwatches, smart bracelets, but also various medical devices, 
even those that are already operating with an application. The key is for the patient to 
choose from readily available mobile solutions. “Fluctuations in blood pressure can be 
linked to events in our lives, we will see how this value changes during sleep or stress 
events… This can lead to disease prevention. This is where today’s “sickness” for patient 
care turns to “health” for health preservation and prevention.” (Szombathelyi, 2020). 
Measurement of therapeutical adherence can similarly provide accurate information about 
the positive (or even unfavorable) effects of medication and related treatment on a disease. 
Most organizations focus on products and delivery channels. Many resources of 
organizations (time, budget, logistics) are devoted to outputs to the customer and internal 
processes (including the experience of the organization’s employees) are ignored while 
service design focuses on these internal processes. Service design enhances the user and 
employee experience by planning, coordinating, and optimizing the organization’s 
operations to better support customer journeys (Gibbons, 2017). 
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It should be noted that it would be easier to develop new products if the exact needs of 
the customers are well known. According to the World Health Organization (2003), this 
approach implies the need for patient-tailored interventions. People-centered 
methodologies, such as design thinking focuses on understanding people’s need help to 
find the most appropriate solution for dedicated problems. First, according to this method, 
the problem is determined by customer compassion based on prototype generation and 
experimentation. During the testing process, the solution can be flexibly modified until 
the product or service is refined. 
A way to improve on patient adherence is to reduce the frequency of dosing. Instead of 
daily or weekly oral dosage forms, monthly, quarterly, or annual dosage forms may be the 
solution. In addition to making dosing more modern and comfortable, another direction 
of drug development, aimed at improving therapeutic adherence, is the development of 
combination drugs to replace several tablets taken in parallel. More convenient delivery 
devices or easier-to-use medical devices can also improve patient collaboration in practice 
(Molnár, 2010). 
It is also useful for the industry to collect medical devices and data from monitoring, 
which allows the creation of databases and registers, so we can also filter by disease groups. 
We can find out how a population produces health status differences according to 
geological location, so other decision-making mechanisms are needed, for which the system 
develops models based on the data, using MI algorithms. In the case of a fairly large 
database, it is possible to analyze the risk on the basis of evidence, to make decisions 
prepared for the doctor, but also to generate lifestyle suggestions. 
3. Methods 
The main goal of the research is to examine the digital tools of patient education in 
Hungarian society. Exploring digital tools and technologies that can contribute to the 
development of health awareness and education, monitoring and measuring therapy for 
various diseases, so that science as well as pharmaceutical and technology companies can 
apply the results of research (Papp-Zipernovszky et al., 2016). However, an important 
goal is to map adherence support solutions for different generations and to find best 
practices and technologies for each research cohort. There is a lack of such accurate 
research data in the literature, although it is particularly important how confidently and 
regularly how different generations of social groups would use such digital tools and 
solutions, on which healthcare can also build. The aim is also for the research to assess 
what solutions are currently available to reduce non-adherence and to what segment of 
society they reach. Examined by location and age, we can get an accurate picture of 
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therapeutic adherence related to disease groups by collecting perceptions and therapeutic 
attitudes. With the analysis of persistence, the degree of cooperation between different 
diseases, countries, or groups of patients and the factors influencing it to become 
comparable. In the course of literature research, I first examine the international 
experience, with special regard to the Central and Eastern European region, and then 
with company and industry research, I continue to explore the background of the topic, 
fine-tune the research areas, and research questions. Expert and corporate interviews 
would be conducted using the method of semi-structured qualitative in-depth interviews, 
followed by data collection from population questionnaires, quantitative and qualitative 
data recording, and statistical data analysis. After disseminating the results obtained in 
this way, preparing case studies and providing feedback to the participants in the research. 
Summarizing company experiences, formulating proposals and action plans, the aim of 
which is to provide scientific and professional feedback to the participants in the research. 
I evaluate the Hungarian population by participating in activities at a pharmaceutical 
company and using a questionnaire method. The series of events, already available in 82 
cities, also includes free health screenings, counseling, sports programs, and interactive, 
motivational lectures. Furthermore, to assessing their own health status, visitors are 
encouraged to participate in support of local health institutions in addition to unnoticed 
deepening of contact with local professionals. Among other activities of the company, this 
program provides an opportunity to partially answer research questions, thus providing 
an excellent opportunity to study the therapeutic adherence habits of the population living 
in different parts of the country for a wide range of age groups. Questionnaire data 
collection allows the mapping of participants’ attitudes to adherence along a 
comprehensive study of patient attitudes. 
In addition to processing the literature and questionnaires, I would like to gather practical 
problems and questions through interviews with several experts and target groups that 
can help determine the effectiveness of adherence, especially the practices and tools used. 





The design and execution of therapeutic processes play a key role in abandoning therapy. 
In order to achieve high adherence, the goal is to develop health services that coordinate 
the actors involved, the infrastructure, the communication, and the material components 
in order to improve the user experience. Moreover, in addition to patient care, these new 
solutions can also be used in the field of risk analysis in connection with epidemic data 
collection. A poorly designed service process can make life particularly difficult for patients 
with otherwise medical difficulties, which can further worsen adherence. As a user-
centered methodology, service design can play a prominent role in the design of 
therapeutic services, contributing to the reduction of uncertainties in innovation processes. 
5. Discussion and recommendations 
The questions of the research highlight the shortcomings of the sector, and its results are 
thus suitable for influencing the innovation processes of the partner company and the 
whole sector, and in a broader sense for a positive effect on the preservation of the health 
of society. In addition to healthcare providers, the tangible results of the hypothesis testing 
have a value-creating effect for pharmaceutical companies as well, as it provides input for 
the development of more focused product and service innovations, as well as their usability 
in patient-centered lighting. Increasing therapeutic adherence is also reflected at the 
economic level, but its social benefits are indisputable. Improving health status, increasing 
age, fewer interventions; requires fewer long-term hospitalizations, thereby relieving the 
health care chain. 
“Patient care data is the new source of innovation and competitiveness for the pharma 
companies as the real-world evidence. It is obvious that these market challenges and 
requirements can’t be met with the current products, business models, and operations. 
Therefore, the pharma business transformation is inevitable which will lead to the 
digitalization of the pharma products, business models, operations and ultimately – the 
patient care” (Kemppainen & Liikkanen, 2017). 
The research fills a gap in several respects, so it contributes to the fine-tuning of service 
and product development processes with digital solutions, not only in Hungary but also 
internationally. Everything, that is done to improve therapy follow-up, has significant 
social value, as it directly increases the age of the population, improves the quality of life, 
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